Guodong Xu

2.8k citations
69 papers · 1.2k indexed · h-index 20
Topics
Cerebrovascular and Carotid Artery Diseases (7 papers)Epigenetics and DNA Methylation (7 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)

In The Last Decade

Guodong Xu

63 papers receiving 1.1k citations

Peers

Guodong Xu
Comparison fields: 5 of 125
  • Molecular Biology 271
  • Public Health, Environmental and Occupational Health 214
  • Physiology 193
  • Cardiology and Cardiovascular Medicine 177
  • Epidemiology 156
Replace Xiaojing Xu with:
Xiaojing Xu China
Peter Henneman Netherlands
Ida Surakka United States
Jan Bressler United States
Jason C. Simeone United States
Jörg Dötsch Germany
Rodolfo Cotichini Italy
Youxue Liu China
Jieyun Yin China
Gary M. Leong Australia
Guodong Xu relative to Xiaojing Xu China Xiaojing Xu's profile →
Citations per field
00.5×
Xiaojing Xu · 1×
Citations per year

Countries citing papers authored by Guodong Xu

Since Specialization
Citations

This map shows the geographic impact of Guodong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guodong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guodong Xu more than expected).

Fields of papers citing papers by Guodong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guodong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guodong Xu. The network helps show where Guodong Xu may publish in the future.

Co-authorship network of co-authors of Guodong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Guodong Xu. A scholar is included among the top collaborators of Guodong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guodong Xu. Guodong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 2
4 10
5 73
6 6
7 23
8 39
9 29
10 31
11 17
12 10
13 6
14 14
15 37
16 19
17 10
18 102
19 40
20 160

About Guodong Xu

Guodong Xu is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health, having authored 69 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (7 papers), Epigenetics and DNA Methylation (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). The work is most often cited by research in Neurology (91 citations), Cardiology and Cardiovascular Medicine (177 citations) and Physiology (193 citations). Guodong Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liyuan Han, Tingbo Liang, Xuning Shen, Tao Ma, Xuefeng Xia, Wei Chen, Xueli Bai, Guangliang Shan, Fen Dong and Haiying Gong. Their work appears in journals such as The Lancet, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026